| Filed On | Filing |
|---|---|
| 21 Oct 2026 | CURRENT REPORT |
| 21 Oct 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
This Amendment No. 1 (this "Amendment") is entered into as of October 13, 2026, by and between Drugs Made In America Acquisition Corp., a Cayman Islands exempted company (the "Company"), and Power Analytics Global Corp, a Delaware corpor... |
| 14 Sep 2026 | CURRENT REPORT |
| 14 Sep 2026 |
8-K: Entry into a Material Definitive Agreement
amending and restating the Definitive Merger Agreement dated April 29, 2026, as amended |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | QUARTERLY REPORT |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 20 Jul 2026 | CURRENT REPORT |
| 20 Jul 2026 | 8-K: Entry into a Material Definitive Agreement |
| 26 Jun 2026 | SCHEDULE 13G |
| 14 May 2026 | QUARTERLY REPORT |
| 14 May 2026 | SCHEDULE 13G |
| 05 May 2026 | CURRENT REPORT |
| 05 May 2026 | 8-K: Entry into a Material Definitive Agreement |
| 01 May 2026 | 8-K: Amendments to Articles/Bylaws; Change in Fiscal Year; Submission of Matters to a Vote of Security Holders +1 more |
| 28 Apr 2026 | 8-K: Entry into a Material Definitive Agreement |
| 16 Apr 2026 | REVISED DEFINITIVE PROXY STATEMENT |
| 15 Apr 2026 | ANNUAL REPORT |
Loading...
